APA (7th ed.) Citation

T, T., T, M., T, A., K, A., N, I., E, S., . . . Y, T. (2022). Efficacy and safety of filgotinib in Japanese patients with refractory rheumatoid arthritis: Subgroup analyses of a global phase 3 study (FINCH 2). Modern rheumatology, 32(1), 59. https://doi.org/10.1080/14397595.2020.1859675

Chicago Style (17th ed.) Citation

T, Takeuchi, et al. "Efficacy and Safety of Filgotinib in Japanese Patients with Refractory Rheumatoid Arthritis: Subgroup Analyses of a Global Phase 3 Study (FINCH 2)." Modern Rheumatology 32, no. 1 (2022): 59. https://doi.org/10.1080/14397595.2020.1859675.

MLA (9th ed.) Citation

T, Takeuchi, et al. "Efficacy and Safety of Filgotinib in Japanese Patients with Refractory Rheumatoid Arthritis: Subgroup Analyses of a Global Phase 3 Study (FINCH 2)." Modern Rheumatology, vol. 32, no. 1, 2022, p. 59, https://doi.org/10.1080/14397595.2020.1859675.